1 study found for:    antineoplaston | Phase 3
Show Display Options
Rank Status Study
1 Not yet recruiting A Randomized Study of Antineoplaston Therapy vs. Temozolomide in Subjects With Recurrent and / or Progressive Optic Pathway Glioma
Condition: Optic Nerve Glioma
Interventions: Drug: Temozolomide;   Drug: Antineoplaston A10 and Antineoplaston AS2-1 (ANP)

Indicates status has not been verified in more than two years